炎症性肠病规范化药物治疗

Standardized medication of inflammatory bowel disease

炎症性肠病在我国发病率逐年升高,病人需要长期药物治疗以诱导并维持病情缓解。规范化的药物治疗需要在充分认识各种药物的作用效果和不良反应基础上,结合病人的病变部位、疾病类型、病情严重程度、并发症以及既往治疗史,制定最适宜的规范化治疗方案。

The incidence of inflammatory bowel disease in China is increasing year by year. It needs long-term therapy to induce and maintain remission. Standardized medication is based on the fully understanding of various drugs effects and adverse effects,combined with the patient’s lesion location, type of disease, severity, complications and previous treatment history, proposed the most appropriate standardized treatment.